Main competitors
Revenues (N-1) Net Margin (N-1) EBIT Margin (N-1) ROE (N-1) ROA (N-1) Leverage (N-1)
982M -42.39%-44.53% - -13.04%-1.37x
4.12B 10.85%15.45%10.86%7.83%0.04x
621M 40.32%46.55%22.85%20.5%-0.42x
1.54B 15.15%36.02%21.45% - 0.36x
812M -8.38%5.56%-219.15%-9.27%-3.06x
1.23B 15.78%25.57%11.2%5.74%1.57x
355M 64.38% - - - -
613M 26.71%27.86%13.92%10.2% -
643M -6.77%-17.25%-5.78%-4.44%7.01x
217M 6.33%8.56%2.77%1.88% -
69.99M -35.08%-33.66%-5.7%-5.21% -
200M 18.9%19.05%3.7%3.23% -
326M 14.24%21.7%3.9%3.04%0.78x
1.14B 0.67%4.26%1.29%0.39% -
420M 18.33%20.78%10.88%8.69% -
152M 22.98%26.42%14.37%11.66%-2.37x
227M 32.11%37.62%13.64%9.91% -
349M 4.98%6.67%1.98% - -
Average 779M 11.06% 12.15% -6.11% 3.41% 0.28x
Weighted average by Cap. 1.42B 5.27% 7.17% -11.8% 1.88% -0.17x
Diagnostic & Testing Substances
SPRING SALE -40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW